Anti-TGFB1/ CED/ DPD1 monoclonal antibody
Anti-TGFB1/ CED/ DPD1 antibody for FACS & in-vivo assay
Go to TGFB1/TGFB1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T97257-Ab-1/ GM-Tg-hg-T97257-Ab-2 | Anti-Human TGFB1 monoclonal antibody | Human |
GM-Tg-rg-T97257-Ab-1/ GM-Tg-rg-T97257-Ab-2 | Anti-Rat TGFB1 monoclonal antibody | Rat |
GM-Tg-mg-T97257-Ab-1/ GM-Tg-mg-T97257-Ab-2 | Anti-Mouse TGFB1 monoclonal antibody | Mouse |
GM-Tg-cynog-T97257-Ab-1/ GM-Tg-cynog-T97257-Ab-2 | Anti-Cynomolgus/ Rhesus macaque TGFB1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T97257-Ab-1/ GM-Tg-felg-T97257-Ab-2 | Anti-Feline TGFB1 monoclonal antibody | Feline |
GM-Tg-cang-T97257-Ab-1/ GM-Tg-cang-T97257-Ab-2 | Anti-Canine TGFB1 monoclonal antibody | Canine |
GM-Tg-bovg-T97257-Ab-1/ GM-Tg-bovg-T97257-Ab-2 | Anti-Bovine TGFB1 monoclonal antibody | Bovine |
GM-Tg-equg-T97257-Ab-1/ GM-Tg-equg-T97257-Ab-2 | Anti-Equine TGFB1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T97257-Ab-1/ GM-Tg-hg-T97257-Ab-2; GM-Tg-rg-T97257-Ab-1/ GM-Tg-rg-T97257-Ab-2; GM-Tg-mg-T97257-Ab-1/ GM-Tg-mg-T97257-Ab-2; GM-Tg-cynog-T97257-Ab-1/ GM-Tg-cynog-T97257-Ab-2; GM-Tg-felg-T97257-Ab-1/ GM-Tg-felg-T97257-Ab-2; GM-Tg-cang-T97257-Ab-1/ GM-Tg-cang-T97257-Ab-2; GM-Tg-bovg-T97257-Ab-1/ GM-Tg-bovg-T97257-Ab-2; GM-Tg-equg-T97257-Ab-1/ GM-Tg-equg-T97257-Ab-2 |
Products Name | Anti-TGFB1 monoclonal antibody |
Format | mab |
Target Name | TGFB1 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-TGFB1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Target information
Target ID | GM-T97257 |
Target Name | TGFB1 |
Gene ID | 7040,21803,59086,106992315,403998,768263,282089,100033900 |
Gene Symbol and Synonyms | CED,DPD1,IBDIMDE,LAP,TGF-beta,TGF-beta1,TGFB,Tgfb-1,TGFB1,TGFbeta,TGFbeta1 |
Uniprot Accession | P01137,P17246,P54831,P18341,O19011 |
Uniprot Entry Name | TGFB1_HUMAN,TGFB1_RAT,TGFB1_CANLF,TGFB1_BOVIN,TGFB1_HORSE |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target |
Disease | bladder cancer, Chronic Kidney Disease, Diabetic Nephropathy, Type 2 diabetes mellitus, Type 1 diabetes mellitus, Sickle Cell Nephropathy, Renal tubulo-interstitial diseases, Malignant neoplasm of bladder, Lupus Glomerulonephritis, Kidney disease |
Gene Ensembl | ENSG00000105329 |
Target Classification | Checkpoint-Immuno Oncology |
The target: TGFB1, gene name: TGFB1, also named as CED, DPD1, LAP, TGFB, TGFbeta. This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.